Cancer Prevention News

The FDA has approved Guardant Health’s Shield blood test to screen for colorectal cancer in patients aged 45 years and older at average risk for disease, according to a company press release.

Informing patients of the benefit-harm balance associated with mammography screening is beneficial and did not hinder overall screening decisions, according to results of a national probability-based U.S. survey.

The rate of cancer-related suicides in the U.S. declined considerably in the past few decades, results of a population-based retrospective study published in Translational Psychiatry showed.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.

Robert A. Winn, MD, FAACR, first called for celebration.

ORLANDO — Adults with obesity who reduce their body weight lower their odds for developing an obesity-related cancer, according to data presented at the American Diabetes Association Scientific Sessions.

Having a tattoo was associated with a 21% increased risk for lymphoma, but more research is needed to better understand the possible connection, according to experts.

The American Cancer Society has launched VOICES of Black Women, a large long-term population study of cancer risk and outcomes among Black women in the United States.

An FDA advisory committee has voted strongly in favor of approval for Guardant Health’s blood test for colorectal cancer, intended for patients aged 45 years and older at average risk for disease.